Pain in extremity and Visual field defect

Summary:

Visual field defect is found among people with Pain in extremity, especially for people who are female, 60+ old.

The study analyzes which people have Visual field defect with Pain in extremity. It is created by eHealthMe based on reports of 14 people who have Pain in extremity from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Pain in extremity?

Pain in extremity is found to be associated with 3,237 drugs and 4,292 conditions by eHealthMe. Check the latest studies of Pain in extremity.

What is Visual field defect?

Visual field defect is found to be associated with 767 drugs and 1,037 conditions by eHealthMe. Check the latest studies of Visual field defect.



On Jul, 15, 2026

14 people who have Pain In Extremity and Visual Field Defect are studied.

Would you have Visual field defect when you have Pain in extremity?

Gender of people who have Pain In Extremity and experienced Visual Field Defect *:

  • female: 61.54 %
  • male: 38.46 %

Age of people who have Pain In Extremity and experienced Visual Field Defect *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 16.67 %
  • 30-39: 8.33 %
  • 40-49: 0.0 %
  • 50-59: 25.0 %
  • 60+: 50.0 %

Common co-existing conditions for these people *:

  1. Pain: 7 people, 50.00%
  2. Insomnia (sleeplessness): 4 people, 28.57%
  3. Nerve Injury: 4 people, 28.57%
  4. Joint Pain: 3 people, 21.43%
  5. Facial Neuralgia (pain of face): 3 people, 21.43%
  6. Temporal Arteritis (inflammation and damage to blood vessels that supply the head area): 3 people, 21.43%
  7. Musculoskeletal Stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves): 2 people, 14.29%
  8. Eye Pain: 2 people, 14.29%
  9. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 14.29%
  10. Headache (pain in head): 2 people, 14.29%

Common drugs taken by these people *:

  1. Lyrica: 9 people, 64.29%
  2. Neurontin: 4 people, 28.57%
  3. Zopiclone: 3 people, 21.43%
  4. Viread: 3 people, 21.43%
  5. Invirase: 3 people, 21.43%
  6. Retrovir: 3 people, 21.43%
  7. Lamictal: 3 people, 21.43%
  8. Norvir: 3 people, 21.43%
  9. Medrol: 2 people, 14.29%
  10. Aubagio: 2 people, 14.29%

Common symptoms for these people *:

  1. Blindness: 7 people, 50.00%
  2. Visual Impairment: 6 people, 42.86%
  3. Vision Blurred: 5 people, 35.71%
  4. Weight Decreased: 4 people, 28.57%
  5. Constipation: 3 people, 21.43%
  6. Chromatopsia (visual defect in which colourless objects appear to be tinged with colour): 3 people, 21.43%
  7. Dysgraphia (impaired ability to learn to write): 3 people, 21.43%
  8. Dry Mouth: 3 people, 21.43%
  9. Dry Eyes (lack of adequate tears): 3 people, 21.43%
  10. Neuropathy Peripheral (surface nerve damage): 3 people, 21.43%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Visual field defect?

- Check whether Visual field defect is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Visual field defect:

All the conditions that are associated with Visual field defect:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Visual field defect and Pain in extremity, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: